drugset / Trial / NCT00659958
ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to acquire additional information about the appropriate level of dosing of Zonisamide when it is prescribed for patients with partial onset epileptic crisis who are already being treated with two other antiepileptic drugs.
Timeline
- Start
- 2008-04
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zonisamide | Other / unclassified | 200 mg | — |
| Subject | Zonisamide | Other / unclassified | 300 mg | — |
| Subject | Zonisamide | Other / unclassified | 400 mg | — |
| Subject | Zonisamide | Other / unclassified | 500 mg | — |